世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

抗うつ薬の世界市場の洞察と2028年までの予測


Global Anti-depressant Drugs Market Insights and Forecast to 2028

抗うつ剤は、大うつ病をはじめ、ジスキミア、不安障害、強迫性障害、摂食障害、慢性疼痛、神経因性疼痛、場合によっては月経困難症、いびき、片頭痛、注意欠陥多動性障害(ADHD)、中毒、依存、睡眠障害などの治... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年1月14日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

抗うつ剤は、大うつ病をはじめ、ジスキミア、不安障害、強迫性障害、摂食障害、慢性疼痛、神経因性疼痛、場合によっては月経困難症、いびき、片頭痛、注意欠陥多動性障害(ADHD)、中毒、依存、睡眠障害などの治療に用いられる薬剤です。これらの薬は、単独で処方されることもあれば、他の薬と組み合わせて処方されることもあります。
市場分析と洞察。抗うつ薬の世界市場
COVID-19の流行により、抗うつ剤の世界市場規模は2022年に11910百万米ドル、2028年には13890百万米ドルになると予測されています(CAGR 2.6%)。この健康危機による経済的変化を十分に考慮して、選択的セロトニン再取り込み阻害剤(SSRI)は、2021年に抗うつ薬の世界市場の%を占めていましたが、2028年には100万米ドルになると予測され、COVID-19以降の期間に改訂された%のCAGRで成長しています。一方、大うつ病性障害のセグメントは、この予測期間を通じて%のCAGRで変化しています。
抗うつ薬市場:うつ病性障害(大うつ病、強迫性障害、全般性不安障害、パニック障害、その他)、製品別(三環系抗うつ薬、選択的セロトニン再取り込み阻害薬、セロトニン-ノルエピネフリン再取り込み阻害薬、モノアミン酸化酵素阻害薬、セロトニン拮抗薬および再取り込み阻害薬、その他)。
世界の抗うつ薬のスコープとセグメント
抗うつ薬市場は、タイプ別、アプリケーション別に分類されています。世界の抗うつ薬市場のプレーヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント分析では、2017年から2028年の期間におけるタイプ別、アプリケーション別の売上高、収益、予測に焦点を当てています。
タイプ別セグメント
選択的セロトニン再取り込み阻害剤(SSRI)
セロトニン・ノルエピネフリン再取り込み阻害剤(SNRI)
三環系抗うつ剤(TCA)
モノアミン酸化酵素阻害剤(MAOI)
その他
用途別セグメント
大うつ病性障害
強迫性障害(Obsessive-Compulsive Disorder)
全般性不安障害
パニック障害
その他
会社別
アルカーメス
アラガン社
ブリストル・マイヤーズ スクイブ(Bristol-Myers Squibb
イーライ・リリー・アンド・カンパニー
グラクソ・スミスクライン(GlaxoSmithKline
Lundbeck
メルク
ファイザー
テバ・ファーマシューティカル・インダストリーズ
武田薬品工業
アストラゼネカ
ジョンソン・アンド・ジョンソン
サノフィ
サン・ファーマシューティカルズ
地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
U.A.E.


ページTOPに戻る


目次

1 Study Coverage
1.1 Anti-depressant Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Anti-depressant Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Selective Serotonin Reuptake Inhibitor (SSRI)
1.2.3 Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
1.2.4 Tricyclic Antidepressant (TCA)
1.2.5 Monoamine Oxidase Inhibitor (MAOI)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Anti-depressant Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Major Depressive Disorder
1.3.3 Obsessive-Compulsive Disorder
1.3.4 Generalized Anxiety Disorder
1.3.5 Panic Disorder
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anti-depressant Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Anti-depressant Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Anti-depressant Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Anti-depressant Drugs Sales by Region
2.4.1 Global Anti-depressant Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Anti-depressant Drugs by Region (2023-2028)
2.5 Global Anti-depressant Drugs Revenue by Region
2.5.1 Global Anti-depressant Drugs Revenue by Region (2017-2022)
2.5.2 Global Anti-depressant Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Anti-depressant Drugs Sales by Manufacturers
3.1.1 Global Top Anti-depressant Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Anti-depressant Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-depressant Drugs in 2021
3.2 Global Anti-depressant Drugs Revenue by Manufacturers
3.2.1 Global Anti-depressant Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Anti-depressant Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Anti-depressant Drugs Revenue in 2021
3.3 Global Anti-depressant Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Anti-depressant Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Anti-depressant Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti-depressant Drugs Sales by Type
4.1.1 Global Anti-depressant Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Anti-depressant Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Anti-depressant Drugs Sales Market Share by Type (2017-2028)
4.2 Global Anti-depressant Drugs Revenue by Type
4.2.1 Global Anti-depressant Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Anti-depressant Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Anti-depressant Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Anti-depressant Drugs Price by Type
4.3.1 Global Anti-depressant Drugs Price by Type (2017-2022)
4.3.2 Global Anti-depressant Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Anti-depressant Drugs Sales by Application
5.1.1 Global Anti-depressant Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Anti-depressant Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Anti-depressant Drugs Sales Market Share by Application (2017-2028)
5.2 Global Anti-depressant Drugs Revenue by Application
5.2.1 Global Anti-depressant Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Anti-depressant Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Anti-depressant Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Anti-depressant Drugs Price by Application
5.3.1 Global Anti-depressant Drugs Price by Application (2017-2022)
5.3.2 Global Anti-depressant Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Anti-depressant Drugs Market Size by Type
6.1.1 North America Anti-depressant Drugs Sales by Type (2017-2028)
6.1.2 North America Anti-depressant Drugs Revenue by Type (2017-2028)
6.2 North America Anti-depressant Drugs Market Size by Application
6.2.1 North America Anti-depressant Drugs Sales by Application (2017-2028)
6.2.2 North America Anti-depressant Drugs Revenue by Application (2017-2028)
6.3 North America Anti-depressant Drugs Market Size by Country
6.3.1 North America Anti-depressant Drugs Sales by Country (2017-2028)
6.3.2 North America Anti-depressant Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Anti-depressant Drugs Market Size by Type
7.1.1 Europe Anti-depressant Drugs Sales by Type (2017-2028)
7.1.2 Europe Anti-depressant Drugs Revenue by Type (2017-2028)
7.2 Europe Anti-depressant Drugs Market Size by Application
7.2.1 Europe Anti-depressant Drugs Sales by Application (2017-2028)
7.2.2 Europe Anti-depressant Drugs Revenue by Application (2017-2028)
7.3 Europe Anti-depressant Drugs Market Size by Country
7.3.1 Europe Anti-depressant Drugs Sales by Country (2017-2028)
7.3.2 Europe Anti-depressant Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anti-depressant Drugs Market Size by Type
8.1.1 Asia Pacific Anti-depressant Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Anti-depressant Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Anti-depressant Drugs Market Size by Application
8.2.1 Asia Pacific Anti-depressant Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Anti-depressant Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Anti-depressant Drugs Market Size by Region
8.3.1 Asia Pacific Anti-depressant Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Anti-depressant Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Anti-depressant Drugs Market Size by Type
9.1.1 Latin America Anti-depressant Drugs Sales by Type (2017-2028)
9.1.2 Latin America Anti-depressant Drugs Revenue by Type (2017-2028)
9.2 Latin America Anti-depressant Drugs Market Size by Application
9.2.1 Latin America Anti-depressant Drugs Sales by Application (2017-2028)
9.2.2 Latin America Anti-depressant Drugs Revenue by Application (2017-2028)
9.3 Latin America Anti-depressant Drugs Market Size by Country
9.3.1 Latin America Anti-depressant Drugs Sales by Country (2017-2028)
9.3.2 Latin America Anti-depressant Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Anti-depressant Drugs Market Size by Type
10.1.1 Middle East and Africa Anti-depressant Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Anti-depressant Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Anti-depressant Drugs Market Size by Application
10.2.1 Middle East and Africa Anti-depressant Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Anti-depressant Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Anti-depressant Drugs Market Size by Country
10.3.1 Middle East and Africa Anti-depressant Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Anti-depressant Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Alkermes
11.1.1 Alkermes Corporation Information
11.1.2 Alkermes Overview
11.1.3 Alkermes Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Alkermes Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Alkermes Recent Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Overview
11.2.3 Allergan Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Allergan Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Allergan Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Corporation Information
11.3.2 Bristol-Myers Squibb Overview
11.3.3 Bristol-Myers Squibb Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bristol-Myers Squibb Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Corporation Information
11.4.2 Eli Lilly and Company Overview
11.4.3 Eli Lilly and Company Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Lilly and Company Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly and Company Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Overview
11.5.3 GlaxoSmithKline Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GlaxoSmithKline Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKline Recent Developments
11.6 Lundbeck
11.6.1 Lundbeck Corporation Information
11.6.2 Lundbeck Overview
11.6.3 Lundbeck Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Lundbeck Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Lundbeck Recent Developments
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Overview
11.7.3 Merck Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Merck Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck Recent Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pfizer Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Corporation Information
11.9.2 Teva Pharmaceutical Industries Overview
11.9.3 Teva Pharmaceutical Industries Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Teva Pharmaceutical Industries Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Teva Pharmaceutical Industries Recent Developments
11.10 Takeda Pharmaceutical Company
11.10.1 Takeda Pharmaceutical Company Corporation Information
11.10.2 Takeda Pharmaceutical Company Overview
11.10.3 Takeda Pharmaceutical Company Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Takeda Pharmaceutical Company Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Takeda Pharmaceutical Company Recent Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Corporation Information
11.11.2 AstraZeneca Overview
11.11.3 AstraZeneca Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 AstraZeneca Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 AstraZeneca Recent Developments
11.12 Johnson and Johnson
11.12.1 Johnson and Johnson Corporation Information
11.12.2 Johnson and Johnson Overview
11.12.3 Johnson and Johnson Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Johnson and Johnson Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Johnson and Johnson Recent Developments
11.13 Sanofi
11.13.1 Sanofi Corporation Information
11.13.2 Sanofi Overview
11.13.3 Sanofi Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Sanofi Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Sanofi Recent Developments
11.14 Sun Pharmaceuticals
11.14.1 Sun Pharmaceuticals Corporation Information
11.14.2 Sun Pharmaceuticals Overview
11.14.3 Sun Pharmaceuticals Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Sun Pharmaceuticals Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Sun Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anti-depressant Drugs Industry Chain Analysis
12.2 Anti-depressant Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-depressant Drugs Production Mode & Process
12.4 Anti-depressant Drugs Sales and Marketing
12.4.1 Anti-depressant Drugs Sales Channels
12.4.2 Anti-depressant Drugs Distributors
12.5 Anti-depressant Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Anti-depressant Drugs Industry Trends
13.2 Anti-depressant Drugs Market Drivers
13.3 Anti-depressant Drugs Market Challenges
13.4 Anti-depressant Drugs Market Restraints
14 Key Findings in The Global Anti-depressant Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る


 

Summary

Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders. They may be prescribed alone or in combination with other medications.
Market Analysis and Insights: Global Anti-depressant Drugs Market
Due to the COVID-19 pandemic, the global Anti-depressant Drugs market size is estimated to be worth US$ 11910 million in 2022 and is forecast to a readjusted size of US$ 13890 million by 2028 with a CAGR of 2.6% during the review period. Fully considering the economic change by this health crisis, Selective Serotonin Reuptake Inhibitor (SSRI) accounting for % of the Anti-depressant Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Major Depressive Disorder segment is altered to an % CAGR throughout this forecast period.
Anti-depressant Drugs Market by Depressive Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others) and Product (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist and Reuptake Inhibitors, and Others)
Global Anti-depressant Drugs Scope and Segment
Anti-depressant Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Anti-depressant Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Selective Serotonin Reuptake Inhibitor (SSRI)
Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
Tricyclic Antidepressant (TCA)
Monoamine Oxidase Inhibitor (MAOI)
Others
Segment by Application
Major Depressive Disorder
Obsessive-Compulsive Disorder
Generalized Anxiety Disorder
Panic Disorder
Others
By Company
Alkermes
Allergan
Bristol-Myers Squibb
Eli Lilly and Company
GlaxoSmithKline
Lundbeck
Merck
Pfizer
Teva Pharmaceutical Industries
Takeda Pharmaceutical Company
AstraZeneca
Johnson and Johnson
Sanofi
Sun Pharmaceuticals
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Anti-depressant Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Anti-depressant Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Selective Serotonin Reuptake Inhibitor (SSRI)
1.2.3 Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
1.2.4 Tricyclic Antidepressant (TCA)
1.2.5 Monoamine Oxidase Inhibitor (MAOI)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Anti-depressant Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Major Depressive Disorder
1.3.3 Obsessive-Compulsive Disorder
1.3.4 Generalized Anxiety Disorder
1.3.5 Panic Disorder
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anti-depressant Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Anti-depressant Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Anti-depressant Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Anti-depressant Drugs Sales by Region
2.4.1 Global Anti-depressant Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Anti-depressant Drugs by Region (2023-2028)
2.5 Global Anti-depressant Drugs Revenue by Region
2.5.1 Global Anti-depressant Drugs Revenue by Region (2017-2022)
2.5.2 Global Anti-depressant Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Anti-depressant Drugs Sales by Manufacturers
3.1.1 Global Top Anti-depressant Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Anti-depressant Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-depressant Drugs in 2021
3.2 Global Anti-depressant Drugs Revenue by Manufacturers
3.2.1 Global Anti-depressant Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Anti-depressant Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Anti-depressant Drugs Revenue in 2021
3.3 Global Anti-depressant Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Anti-depressant Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Anti-depressant Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti-depressant Drugs Sales by Type
4.1.1 Global Anti-depressant Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Anti-depressant Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Anti-depressant Drugs Sales Market Share by Type (2017-2028)
4.2 Global Anti-depressant Drugs Revenue by Type
4.2.1 Global Anti-depressant Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Anti-depressant Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Anti-depressant Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Anti-depressant Drugs Price by Type
4.3.1 Global Anti-depressant Drugs Price by Type (2017-2022)
4.3.2 Global Anti-depressant Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Anti-depressant Drugs Sales by Application
5.1.1 Global Anti-depressant Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Anti-depressant Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Anti-depressant Drugs Sales Market Share by Application (2017-2028)
5.2 Global Anti-depressant Drugs Revenue by Application
5.2.1 Global Anti-depressant Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Anti-depressant Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Anti-depressant Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Anti-depressant Drugs Price by Application
5.3.1 Global Anti-depressant Drugs Price by Application (2017-2022)
5.3.2 Global Anti-depressant Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Anti-depressant Drugs Market Size by Type
6.1.1 North America Anti-depressant Drugs Sales by Type (2017-2028)
6.1.2 North America Anti-depressant Drugs Revenue by Type (2017-2028)
6.2 North America Anti-depressant Drugs Market Size by Application
6.2.1 North America Anti-depressant Drugs Sales by Application (2017-2028)
6.2.2 North America Anti-depressant Drugs Revenue by Application (2017-2028)
6.3 North America Anti-depressant Drugs Market Size by Country
6.3.1 North America Anti-depressant Drugs Sales by Country (2017-2028)
6.3.2 North America Anti-depressant Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Anti-depressant Drugs Market Size by Type
7.1.1 Europe Anti-depressant Drugs Sales by Type (2017-2028)
7.1.2 Europe Anti-depressant Drugs Revenue by Type (2017-2028)
7.2 Europe Anti-depressant Drugs Market Size by Application
7.2.1 Europe Anti-depressant Drugs Sales by Application (2017-2028)
7.2.2 Europe Anti-depressant Drugs Revenue by Application (2017-2028)
7.3 Europe Anti-depressant Drugs Market Size by Country
7.3.1 Europe Anti-depressant Drugs Sales by Country (2017-2028)
7.3.2 Europe Anti-depressant Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anti-depressant Drugs Market Size by Type
8.1.1 Asia Pacific Anti-depressant Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Anti-depressant Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Anti-depressant Drugs Market Size by Application
8.2.1 Asia Pacific Anti-depressant Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Anti-depressant Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Anti-depressant Drugs Market Size by Region
8.3.1 Asia Pacific Anti-depressant Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Anti-depressant Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Anti-depressant Drugs Market Size by Type
9.1.1 Latin America Anti-depressant Drugs Sales by Type (2017-2028)
9.1.2 Latin America Anti-depressant Drugs Revenue by Type (2017-2028)
9.2 Latin America Anti-depressant Drugs Market Size by Application
9.2.1 Latin America Anti-depressant Drugs Sales by Application (2017-2028)
9.2.2 Latin America Anti-depressant Drugs Revenue by Application (2017-2028)
9.3 Latin America Anti-depressant Drugs Market Size by Country
9.3.1 Latin America Anti-depressant Drugs Sales by Country (2017-2028)
9.3.2 Latin America Anti-depressant Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Anti-depressant Drugs Market Size by Type
10.1.1 Middle East and Africa Anti-depressant Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Anti-depressant Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Anti-depressant Drugs Market Size by Application
10.2.1 Middle East and Africa Anti-depressant Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Anti-depressant Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Anti-depressant Drugs Market Size by Country
10.3.1 Middle East and Africa Anti-depressant Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Anti-depressant Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Alkermes
11.1.1 Alkermes Corporation Information
11.1.2 Alkermes Overview
11.1.3 Alkermes Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Alkermes Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Alkermes Recent Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Overview
11.2.3 Allergan Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Allergan Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Allergan Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Corporation Information
11.3.2 Bristol-Myers Squibb Overview
11.3.3 Bristol-Myers Squibb Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bristol-Myers Squibb Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Corporation Information
11.4.2 Eli Lilly and Company Overview
11.4.3 Eli Lilly and Company Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Lilly and Company Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly and Company Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Overview
11.5.3 GlaxoSmithKline Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GlaxoSmithKline Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKline Recent Developments
11.6 Lundbeck
11.6.1 Lundbeck Corporation Information
11.6.2 Lundbeck Overview
11.6.3 Lundbeck Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Lundbeck Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Lundbeck Recent Developments
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Overview
11.7.3 Merck Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Merck Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck Recent Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pfizer Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Corporation Information
11.9.2 Teva Pharmaceutical Industries Overview
11.9.3 Teva Pharmaceutical Industries Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Teva Pharmaceutical Industries Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Teva Pharmaceutical Industries Recent Developments
11.10 Takeda Pharmaceutical Company
11.10.1 Takeda Pharmaceutical Company Corporation Information
11.10.2 Takeda Pharmaceutical Company Overview
11.10.3 Takeda Pharmaceutical Company Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Takeda Pharmaceutical Company Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Takeda Pharmaceutical Company Recent Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Corporation Information
11.11.2 AstraZeneca Overview
11.11.3 AstraZeneca Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 AstraZeneca Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 AstraZeneca Recent Developments
11.12 Johnson and Johnson
11.12.1 Johnson and Johnson Corporation Information
11.12.2 Johnson and Johnson Overview
11.12.3 Johnson and Johnson Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Johnson and Johnson Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Johnson and Johnson Recent Developments
11.13 Sanofi
11.13.1 Sanofi Corporation Information
11.13.2 Sanofi Overview
11.13.3 Sanofi Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Sanofi Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Sanofi Recent Developments
11.14 Sun Pharmaceuticals
11.14.1 Sun Pharmaceuticals Corporation Information
11.14.2 Sun Pharmaceuticals Overview
11.14.3 Sun Pharmaceuticals Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Sun Pharmaceuticals Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Sun Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anti-depressant Drugs Industry Chain Analysis
12.2 Anti-depressant Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-depressant Drugs Production Mode & Process
12.4 Anti-depressant Drugs Sales and Marketing
12.4.1 Anti-depressant Drugs Sales Channels
12.4.2 Anti-depressant Drugs Distributors
12.5 Anti-depressant Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Anti-depressant Drugs Industry Trends
13.2 Anti-depressant Drugs Market Drivers
13.3 Anti-depressant Drugs Market Challenges
13.4 Anti-depressant Drugs Market Restraints
14 Key Findings in The Global Anti-depressant Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(中枢神経系作用薬)の最新刊レポート

本レポートと同じKEY WORD(antidepressant)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14 10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る